Clinical Trial Update: Rifaximin in Patients With Gastroesophageal Variceal Bleeding [NA]

View source ↗

Summary

Clinical trial update notes the completion of a rifaximin study in patients with gastroesophageal variceal bleeding due to cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Esophageal Variceal Bleeding
• Gastric Variceal Bleeding
• Gastrointestinal Hemorrhage

Drugs mentioned

• XIFAXAN (rifaximin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cirrhosis, Esophageal and Gastric Varices | NA | Status: COMPLETED